Zepbound
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
What is Zepbound?
Tirzepatide sold as a weekly injection for weight management, approved 2023.
A dual GLP-1/GIP agonist, and the trial number people quote: about 21% body weight reduction at 15 mg in SURMOUNT-1. The most expensive brand in this register and the one compounded sellers most often position against.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Zepbound comes up on this site
On GLP Watchdog, Zepbound comes up in 11 research articles, 79 seller reviews, 4 FDA warning letters and 4 tools. Browse the FDA warning letters.
Research that discusses it
- Zepbound for Sleep Apnea: What SURMOUNT-OSA Actually Found
- Is Zepbound a Semaglutide? Brand Names vs Molecules
- Does Medicaid Cover Zepbound? The Federal Rule and the Sleep Apnea Indication
- Is There a Tirzepatide Pill? What Sellers Ship
- Constipation on a GLP-1: What the Labels Report and What Actually Helps
- Dizzy on a GLP-1? The Blood-Pressure Question the Labels Skip
- All 11 articles are on the research page
Tools that use it
Seller reviews that mention it
Other terms under Drugs and brands
Where the evidence lives
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers